Published in Arch Pathol Lab Med on September 01, 2013
Eltrombopag modulates reactive oxygen species and decreases acute myeloid leukemia cell survival. PLoS One (2015) 0.76
Transfusion medicine illustrated: Muddy waters in therapeutic plasma exchange. Transfusion (2014) 0.75
A two-amino acid change in the hemagglutinin of the 1918 influenza virus abolishes transmission. Science (2007) 8.38
Glycan microarray analysis of the hemagglutinins from modern and pandemic influenza viruses reveals different receptor specificities. J Mol Biol (2005) 6.17
Control of large, established tumor xenografts with genetically retargeted human T cells containing CD28 and CD137 domains. Proc Natl Acad Sci U S A (2009) 5.36
Blockade of lymphocyte chemotaxis in visceral graft-versus-host disease. N Engl J Med (2012) 3.15
Engineering artificial antigen-presenting cells to express a diverse array of co-stimulatory molecules. Mol Ther (2007) 2.99
Concordance study of 3 direct-to-consumer genetic-testing services. Clin Chem (2010) 2.33
Improving healthcare accessibility through point-of-care technologies. Clin Chem (2007) 2.11
Targeted inhibition of tumor-specific glutaminase diminishes cell-autonomous tumorigenesis. J Clin Invest (2015) 1.67
F-actin polymerization and retrograde flow drive sustained PLCγ1 signaling during T cell activation. J Cell Biol (2012) 1.64
Diagnostic challenges for multiplexed protein microarrays. Drug Discov Today (2006) 1.54
A phase I study of the mammalian target of rapamycin inhibitor sirolimus and MEC chemotherapy in relapsed and refractory acute myelogenous leukemia. Clin Cancer Res (2009) 1.42
The Promise of Chimeric Antigen Receptor T-Cell Therapy. Oncology (Williston Park) (2016) 1.41
4-1BB and CD28 signaling plays a synergistic role in redirecting umbilical cord blood T cells against B-cell malignancies. Hum Gene Ther (2010) 1.40
Characteristics and outcome of acute myeloid leukemia in patients with a prior history of autoimmune disease. Leuk Lymphoma (2013) 1.39
Nanobiotechnology: the promise and reality of new approaches to molecular recognition. Trends Biotechnol (2005) 1.39
Tat-functionalized near-infrared emissive polymersomes for dendritic cell labeling. Bioconjug Chem (2007) 1.28
Microfluidics and point-of-care testing. Lab Chip (2008) 1.15
Micropillar array chip for integrated white blood cell isolation and PCR. Biomol Eng (2005) 1.13
Next-generation sequencing in the clinic. Nat Biotechnol (2013) 1.09
Substrate rigidity regulates human T cell activation and proliferation. J Immunol (2012) 1.09
Functional unresponsiveness and replicative senescence of myeloid leukemia antigen-specific CD8+ T cells after allogeneic stem cell transplantation. Clin Cancer Res (2009) 1.06
Quality control and protein microarrays. Clin Chem (2009) 0.98
Applications of nanoparticles to diagnostics and therapeutics in colorectal cancer. Trends Biotechnol (2007) 0.96
In vivo dendritic cell tracking using fluorescence lifetime imaging and near-infrared-emissive polymersomes. Mol Imaging Biol (2009) 0.96
Fifty years of molecular (DNA/RNA) diagnostics. Clin Chem (2005) 0.96
Oncogenic tyrosine kinase NPM-ALK induces expression of the growth-promoting receptor ICOS. Blood (2011) 0.90
Surface effects on PCR reactions in multichip microfluidic platforms. Biomed Microdevices (2004) 0.89
Molecular diagnostics: hurdles for clinical implementation. Trends Mol Med (2002) 0.88
Prospects for nano- and microtechnologies in clinical point-of-care testing. Lab Chip (2007) 0.88
Genotyping on a thermal gradient DNA chip. Genome Res (2003) 0.88
Lack of TNFalpha expression protects anaplastic lymphoma kinase-positive T-cell lymphoma (ALK+ TCL) cells from apoptosis. Proc Natl Acad Sci U S A (2009) 0.88
Processing controls in blood collection tubes reveals interference. Clin Chem (2005) 0.85
Pilot study of prophylactic ex vivo costimulated donor leukocyte infusion after reduced-intensity conditioned allogeneic stem cell transplantation. Biol Blood Marrow Transplant (2013) 0.84
Cross talk between CD3 and CD28 is spatially modulated by protein lateral mobility. Mol Cell Biol (2013) 0.83
Programmed death ligand-1 expression on donor T cells drives graft-versus-host disease lethality. J Clin Invest (2016) 0.83
Enhanced function of redirected human T cells expressing linker for activation of T cells that is resistant to ubiquitylation. Hum Gene Ther (2012) 0.82
Therapeutic drug monitoring of mycophenolic acid. Clin J Am Soc Nephrol (2007) 0.82
Methotrexate clearance by high-flux hemodialysis and peritoneal dialysis: a case report. Am J Kidney Dis (2009) 0.82
Detection of enteropathogenic Escherichia coli by microchip capillary electrophoresis. Methods Mol Biol (2009) 0.81
Hyponatremia associated with levamisole-adulterated cocaine use in emergency department patients. Ann Emerg Med (2011) 0.80
Increased amplification efficiency of microchip-based PCR by dynamic surface passivation. Biotechniques (2004) 0.79
Nanoengineering of Immune Cell Function. Mater Res Soc Symp Proc (2009) 0.79
Opportunities for near-infrared thermal ablation of colorectal metastases by guanylyl cyclase C-targeted gold nanoshells. Future Oncol (2006) 0.79
Red-shifted emission from 1,2-dioxetane-based chemiluminescent reactions. Luminescence (2014) 0.77
Genomics into Healthcare: the 5th Pan Arab Human Genetics Conference and 2013 Golden Helix Symposium. Hum Mutat (2014) 0.77
Chemiluminescence-based detection of gastrointestinal malignancies. Luminescence (2009) 0.77
Clinical analysis by microchip capillary electrophoresis. Clin Chem (2005) 0.77
CA-125 concentrations in patients awaiting cardiac transplantation. Clin Chem (2002) 0.76
Cytokine Release Syndrome After Chimeric Antigen Receptor T Cell Therapy for Acute Lymphoblastic Leukemia. Crit Care Med (2016) 0.76
Nanotechnology: improving clinical testing? Clin Chem (2010) 0.76
Male infertility and microchips. Clin Chem (2013) 0.75
Use of linkage analysis, genome-wide association studies, and next-generation sequencing in the identification of disease-causing mutations. Methods Mol Biol (2013) 0.75
The next GME accreditation system. N Engl J Med (2012) 0.75
Additive-aggravated assays: an authoritative answer. Clin Chem (2005) 0.75
Biofunctionalization of aqueous dispersed, alumina membrane-templated polymer nanorods for use in enzymatic chemiluminescence assays. Colloids Surf B Biointerfaces (2008) 0.75
Effect of a variable magnetic field on clinical laboratory testing. Clin Chem (2009) 0.75
Protein microarrays: a literature survey. Clin Chem (2003) 0.75
Nanotechnology and immunoassay. Clin Chem (2007) 0.75
Increased risk of citrate reactions in patients with multiple myeloma during peripheral blood stem cell leukapheresis. J Clin Apher (2010) 0.75
Luminometers and the "oldest luminometer in Europe contest". Luminescence (2012) 0.75
Nanotechnology and applications: an all-language literature survey including books and patents. Clin Chem (2002) 0.75
Then and now--a 25-year perspective of the journal Luminescence. Luminescence (2011) 0.75
Nanotechnologic nutraceuticals: nurturing or nefarious? Clin Chem (2006) 0.75
Microchip capillary electrophoresis. Methods Mol Biol (2009) 0.75
Genomic test validation for incidental findings. Clin Chem (2013) 0.75
Improving T Cell Expansion with a Soft Touch. Nano Lett (2017) 0.75
Mutation detection using ligase chain reaction in passivated silicon-glass microchips and microchip capillary electrophoresis. Biotechniques (2004) 0.75
Prospects for the commercialization of chemiluminescence-based point-of-care and on-site testing devices. Anal Bioanal Chem (2014) 0.75
Bioconjugation of alkaline phosphatase to mechanically processed, aqueous suspendible electrospun polymer nanofibers for use in chemiluminescent detection assays. Macromol Biosci (2008) 0.75
Interference from anti-streptavidin antibody. Arch Pathol Lab Med (2013) 0.75
Advancing laboratory medicine through innovation: a tale of six inventors. Clin Chem (2012) 0.75